Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

The role of hemostatic agents in preventing complications in laparoscopic partial nephrectomy.

Carrion DM, Y Gregorio SA, Rivas JG, Bazán AA, Sebastián JD, Martínez-Piñeiro L.

Cent European J Urol. 2017;70(4):362-367. doi: 10.5173/ceju.2017.1432. Epub 2017 Oct 17.

2.

Impact of learning curve on the perioperative outcomes following robot-assisted partial nephrectomy for renal tumors.

Dias BH, Ali MS, Dubey S, Krishnaswamy SA, Rao AR, Dubey D.

Indian J Urol. 2018 Jan-Mar;34(1):62-67. doi: 10.4103/iju.IJU_169_17.

3.

Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.

Bläsius FM, Meller S, Stephan C, Jung K, Ellinger J, Glocker MO, Thiesen HJ, Tolkach Y, Kristiansen G.

Oncotarget. 2017 Aug 24;8(43):75076-75086. doi: 10.18632/oncotarget.20507. eCollection 2017 Sep 26.

4.

Clinical predictors of the estimated glomerular filtration rate 1 year after radical nephrectomy in Japanese patients.

Shimada S, Saito H, Kawasaki Y, Yamashita S, Adachi H, Kakoi N, Namima T, Sato M, Kyan A, Mitsuzuka K, Ito A, Yamaguchi T, Arai Y.

Investig Clin Urol. 2017 Jul;58(4):228-234. doi: 10.4111/icu.2017.58.4.228. Epub 2017 Jun 27.

5.

Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?

Kumar RM, Lavallée LT, Desantis D, Cnossen S, Mallick R, Cagiannos I, Morash C, Breau RH.

Can Urol Assoc J. 2017 Jun;11(6):199-203. doi: 10.5489/cuaj.4228.

6.

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.

Shinder BM, Rhee K, Farrell D, Farber NJ, Stein MN, Jang TL, Singer EA.

Front Oncol. 2017 May 31;7:107. doi: 10.3389/fonc.2017.00107. eCollection 2017. Review.

7.

Perioperative complications and postoperative outcomes of partial nephrectomy for renal cell carcinoma: Does indication matter?

Venkatramani V, Kumar S, Chandrasingh J, Devasia A, Kekre NS.

Indian J Urol. 2017 Apr-Jun;33(2):140-143. doi: 10.4103/0970-1591.203420.

8.

Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery.

Corradi R, Kabra A, Suarez M, Oppenheimer J, Okhunov Z, White H, Nougaret S, Vargas HA, Landman J, Coleman J, Liss MA.

Int Urol Nephrol. 2017 Apr;49(4):615-621. doi: 10.1007/s11255-017-1525-y. Epub 2017 Feb 4.

PMID:
28161843
9.

Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.

Hongo F, Yamada Y, Ueda T, Nakmura T, Naya Y, Kamoi K, Okihara K, Ichijo Y, Miki T, Yamada K, Ukimura O.

BMC Urol. 2017 Jan 18;17(1):10. doi: 10.1186/s12894-017-0199-1.

10.

Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies.

Vetterlein MW, Jindal T, Becker A, Regier M, Kluth LA, Tilki D, Chun FK.

Investig Clin Urol. 2016 Jul;57(4):231-9. doi: 10.4111/icu.2016.57.4.231. Epub 2016 Jul 5. Review.

11.

Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.

Alanee SR, Carver BS, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld J.

Urology. 2016 Sep;95:128-31. doi: 10.1016/j.urology.2016.05.014. Epub 2016 May 25.

12.

Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Wotschofsky Z, Gummlich L, Liep J, Stephan C, Kilic E, Jung K, Billaud JN, Meyer HA.

PLoS One. 2016 Feb 9;11(2):e0148746. doi: 10.1371/journal.pone.0148746. eCollection 2016.

13.

Experience with sliding-clip splenorrhaphy for splenic injury during radical nephrectomy.

Giri SK, Abdelrahman M, Flood HD.

Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E476-9. doi: 10.5489/cuaj.2732.

14.

Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.

Liss MA, DeConde R, Caovan D, Hofler J, Gabe M, Palazzi KL, Patel ND, Lee HJ, Ideker T, Van Poppel H, Karow D, Aertsen M, Casola G, Derweesh IH.

J Endourol. 2016 Jan;30(1):114-21. doi: 10.1089/end.2015.0411. Epub 2015 Sep 25.

15.

Surgical management of stage T1 renal tumours at Canadian academic centres.

Lavallée LT, Tanguay S, Jewett MA, Wood L, Kapoor A, Rendon RA, Moore RB, Lacombe L, Kawakami J, Pautler SE, Drachenberg DE, Black PC, Lattouf JB, Morash C, Cagiannos I, Liu Z, Breau RH.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):99-106. doi: 10.5489/cuaj.2598. Erratum in: Can Urol Assoc J. 2016 Aug;10 (7-8):E281.

16.

A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V, Mottrie A, Porpiglia F, Porter J, Rogers CG, Russo P, Thompson RH, Uzzo RG, Wood CG, Gill IS.

Eur Urol. 2015 Dec;68(6):980-92. doi: 10.1016/j.eururo.2015.04.010. Epub 2015 Apr 22. Review.

17.

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?

Shahait M, Mukherji D, El-Hout Y.

Indian J Urol. 2015 Apr-Jun;31(2):102-5. doi: 10.4103/0970-1591.154300. Review.

18.

Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.

Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH.

BMC Urol. 2014 Dec 17;14:101. doi: 10.1186/1471-2490-14-101.

19.

Renal cell carcinoma.

Jonasch E, Gao J, Rathmell WK.

BMJ. 2014 Nov 10;349:g4797. doi: 10.1136/bmj.g4797. Review.

20.

Clinical efficacy of radical nephrectomy versus nephron-sparing surgery on localized renal cell carcinoma.

Li W, Cheng Y, Cheng Y, Ren H, Han N.

Eur J Med Res. 2014 Nov 6;19:58. doi: 10.1186/s40001-014-0058-4.

Supplemental Content

Support Center